Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression

被引:47
作者
Bugler, Beatrix
Quaranta, Muriel
Aressy, Bernadette
Brezak, Marie-Christine
Prevost, Gregoire
Ducommun, Bernard
机构
[1] Univ Toulouse 3, Lab Biol Cellulaire & Mol Controle Proliferat, CNRS, UMR 5088,IFR 109,Inst Explorat Fonct Genome, F-31062 Toulouse, France
[2] Inst Henri Beaufour, IPSEN, F-91952 Les Ulis, France
关键词
D O I
10.1158/1535-7163.MCT-06-0099
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cell cycle arrest at the G(2)-M checkpoint is an essential feature of the mechanisms that preserve genomic integrity. CDC25 phosphatases control cell cycle progression by dephosphorylating and activating cyclin-dependent kinase/cyclin complexes. Their activities are, therefore, tightly regulated to modulate cell cycle arrest in response to DNA damage exposure. Here, we report that overexpression of CDC25B affects viability, reduces clonogenic efficiency, and increases sensitivity of cancer cells to a genotoxic agent. We show that ectopic expression of CDC25B results in bypass of a genotoxic-induced G(2)-M checkpoint. In addition, cancer cells constitutively expressing high level of CDC25B are shown to be prone to exit prematurely from the G(2)-M checkpoint arrest and to enter mitosis. Finally, we show that this exit is dependent on CDC25B expression. Together with previous results, our data strongly support a model in which CDC25B is the key phosphatase that controls entry into mitosis after DNA damage, thus emphasizing the relevance of its overexpression in many human tumors.
引用
收藏
页码:1446 / 1451
页数:6
相关论文
共 21 条
  • [1] Cell cycle checkpoint signaling through the ATM and ATR kinases
    Abraham, RT
    [J]. GENES & DEVELOPMENT, 2001, 15 (17) : 2177 - 2196
  • [2] The when and wheres of CDC25 phosphatases
    Boutros, R
    Dozier, C
    Ducommun, B
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2006, 18 (02) : 185 - 191
  • [3] Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases
    Brezak, MC
    Quaranta, M
    Contour-Galcera, MO
    Lavergne, O
    Mondesert, O
    Auvray, P
    Kasprzyk, PG
    Prevost, GP
    Ducommun, B
    [J]. MOLECULAR CANCER THERAPEUTICS, 2005, 4 (09) : 1378 - 1387
  • [4] CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage
    Cazales, M
    Schmitt, E
    Montembault, E
    Dozier, C
    Prigent, C
    Ducommun, B
    [J]. CELL CYCLE, 2005, 4 (09) : 1233 - 1238
  • [5] Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding
    Chen, MS
    Ryan, CE
    Piwnica-Worms, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (21) : 7488 - 7497
  • [6] Regulation of CDC25B phosphatases subcellular localization
    Davezac, N
    Baldin, V
    Gabrielli, B
    Forrest, A
    Theis-Febvre, N
    Yashida, M
    Ducommun, B
    [J]. ONCOGENE, 2000, 19 (18) : 2179 - 2185
  • [7] Cell cycle checkpoints: Preventing an identity crisis
    Elledge, SJ
    [J]. SCIENCE, 1996, 274 (5293) : 1664 - 1672
  • [8] A MICROPLATE ASSAY FOR QUANTITATION OF ANCHORAGE-INDEPENDENT GROWTH OF TRANSFORMED-CELLS
    FUKAZAWA, H
    MIZUNO, S
    UEHARA, Y
    [J]. ANALYTICAL BIOCHEMISTRY, 1995, 228 (01) : 83 - 90
  • [9] The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01
    Graves, PR
    Yu, LJ
    Schwarz, JK
    Gales, J
    Sausville, EA
    O'Connor, PM
    Piwnica-Worms, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) : 5600 - 5605
  • [10] Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis
    Karlsson, C
    Katich, S
    Hagting, A
    Hoffmann, I
    Pines, J
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 146 (03) : 573 - 583